메뉴 건너뛰기




Volumn 17, Issue 7, 2010, Pages 1747-1757

Pilot study of sentinel-node-based adoptive immunotherapy in advanced colorectal cancer

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID; ANTINEOPLASTIC AGENT;

EID: 77954960188     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-0920-8     Document Type: Article
Times cited : (54)

References (39)
  • 1
    • 77954954894 scopus 로고    scopus 로고
    • GLOBOCAN 2002. Descriptive Epidemiology Group, International Agency for Research on Cancer. Lyon, France.:, 2002. Accessed 21 Jan 2010
    • Fearly J. GLOBOCAN 2002. Descriptive Epidemiology Group, International Agency for Research on Cancer. Lyon, France.: www-dep. iarc.fr/; 2002. Accessed 21 Jan 2010.
    • Fearly, J.1
  • 3
    • 6944230093 scopus 로고    scopus 로고
    • Colon cancer survival rates with the new American joint committee on cancer sixth edition staging
    • O'Connell JB, Maggard MA, Ko CY. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst. 2004;96:1420-5.
    • (2004) J. Natl. Cancer Inst. , vol.96 , pp. 1420-1425
    • O'Connell, J.B.1    Maggard, M.A.2    Ko, C.Y.3
  • 4
    • 0025060806 scopus 로고
    • Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma
    • Moertel CG, Fleming TR, Macdonald JS, et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med. 1990;322:352-8.
    • (1990) N. Engl. J. Med. , vol.322 , pp. 352-358
    • Moertel, C.G.1    Fleming, T.R.2    Macdonald, J.S.3
  • 5
    • 0028956045 scopus 로고
    • Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: A final report
    • Moertel CG, Fleming TR, Macdonald JS, et al. Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report. Ann Intern Med. 1995;122:321-6.
    • (1995) Ann. Intern. Med. , vol.122 , pp. 321-326
    • Moertel, C.G.1    Fleming, T.R.2    Macdonald, J.S.3
  • 6
    • 36849064682 scopus 로고    scopus 로고
    • Adjuvant chemotherapy versus observation in patients with colorectal cancer: A randomised study
    • Quasar Collaborative G, Gray R, Barnwell J, et al. Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study. Lancet. 2007;370:2020-9.
    • (2007) Lancet , vol.370 , pp. 2020-2029
    • Collaborative, G.Q.1    Gray, R.2    Barnwell, J.3
  • 7
    • 0037566566 scopus 로고
    • Cancer of the large bowel
    • Mayo C. Cancer of the large bowel. Med Sentinel. 1904;12:466-73.
    • (1904) Med. Sentinel , vol.12 , pp. 466-473
    • Mayo, C.1
  • 8
    • 0037266824 scopus 로고    scopus 로고
    • The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined
    • Swanson RS, Compton CC, Stewart AK, Bland KI. The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol. 2003;10:65-71.
    • (2003) Ann. Surg. Oncol. , vol.10 , pp. 65-71
    • Swanson, R.S.1    Compton, C.C.2    Stewart, A.K.3    Bland, K.I.4
  • 9
    • 0017331560 scopus 로고
    • An approach for the treatment of penile carcinoma
    • Cabanas RM. An approach for the treatment of penile carcinoma. Cancer. 1977;39:456-66.
    • (1977) Cancer , vol.39 , pp. 456-466
    • Cabanas, R.M.1
  • 10
    • 17144420503 scopus 로고    scopus 로고
    • Identification of sentinel nodes in patients with colon cancer
    • Dahl K, Westlin J, Kraaz W, et al. Identification of sentinel nodes in patients with colon cancer. Eur J Surg Oncol. 2005;31:381-5.
    • (2005) Eur. J. Surg. Oncol. , vol.31 , pp. 381-385
    • Dahl, K.1    Westlin, J.2    Kraaz, W.3
  • 11
    • 3042756948 scopus 로고    scopus 로고
    • Sentinel lymph node mapping technique in colon cancer
    • Saha S, Dan AG, Beutler T, et al. Sentinel lymph node mapping technique in colon cancer. Semin Oncol. 2004;31:374-81.
    • (2004) Semin. Oncol. , vol.31 , pp. 374-381
    • Saha, S.1    Dan, A.G.2    Beutler, T.3
  • 12
    • 33646851253 scopus 로고    scopus 로고
    • Sentinel node lymphocytes: Tumour reactive lymphocytes identified intraoperatively for the use in immunotherapy of colon cancer
    • Marits P, Karlsson M, Dahl K, et al. Sentinel node lymphocytes: tumour reactive lymphocytes identified intraoperatively for the use in immunotherapy of colon cancer. Br J Cancer. 2006;94:1478-84.
    • (2006) Br. J. Cancer , vol.94 , pp. 1478-1484
    • Marits, P.1    Karlsson, M.2    Dahl, K.3
  • 13
    • 29044444695 scopus 로고    scopus 로고
    • Detection of immune responses against urinary bladder cancer in sentinel lymph nodes
    • Marits P, Karlsson M, Sherif A, et al. Detection of immune responses against urinary bladder cancer in sentinel lymph nodes. Eur Urol. 2006;49:59-70.
    • (2006) Eur. Urol. , vol.49 , pp. 59-70
    • Marits, P.1    Karlsson, M.2    Sherif, A.3
  • 14
    • 41549128459 scopus 로고    scopus 로고
    • Metinel node-the first lymph node draining a metastasis-contains tumor-reactive lymphocytes
    • Dahl K, Karlsson M, Marits P, et al. Metinel node-the first lymph node draining a metastasis-contains tumor-reactive lymphocytes. Ann Surg Oncol. 2008;15:1454-63.
    • (2008) Ann. Surg. Oncol. , vol.15 , pp. 1454-1463
    • Dahl, K.1    Karlsson, M.2    Marits, P.3
  • 15
    • 0035925638 scopus 로고    scopus 로고
    • Adjuvant active specific immunotherapy of stage II and stage III colon cancer with an autologous tumor cell vaccine: First randomized phase III trials show promise
    • Hanna MG, Jr, Hoover HC, Jr, Vermorken JB, et al. Adjuvant active specific immunotherapy of stage II and stage III colon cancer with an autologous tumor cell vaccine: first randomized phase III trials show promise. Vaccine. 2001;19:2576-82.
    • (2001) Vaccine , vol.19 , pp. 2576-2582
    • Hanna Jr., M.G.1    Hoover Jr., H.C.2    Vermorken, J.B.3
  • 16
    • 9644303122 scopus 로고    scopus 로고
    • Colorectal cancer vaccines: Principles, results, and perspectives
    • Mocellin S, Rossi CR, Lise M, Nitti D. Colorectal cancer vaccines: principles, results, and perspectives. Gastroenterology. 2004;127:1821-37.
    • (2004) Gastroenterology , vol.127 , pp. 1821-1837
    • Mocellin, S.1    Rossi, C.R.2    Lise, M.3    Nitti, D.4
  • 17
    • 0035902607 scopus 로고    scopus 로고
    • Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immuno-therapy
    • Fong L, Hou Y, Rivas A, et al. Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immuno-therapy. Proc Natl Acad Sci USA. 2001;98:8809-14.
    • (2001) Proc. Natl. Acad. Sci. USA , vol.98 , pp. 8809-8814
    • Fong, L.1    Hou, Y.2    Rivas, A.3
  • 18
    • 20244366111 scopus 로고    scopus 로고
    • Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma
    • Dudley ME, Wunderlich JR, Yang JC, et al. Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. J Clin Oncol. 2005;23:2346-57.
    • (2005) J. Clin. Oncol. , vol.23 , pp. 2346-2357
    • Dudley, M.E.1    Wunderlich, J.R.2    Yang, J.C.3
  • 19
    • 33749624177 scopus 로고    scopus 로고
    • Cancer regression in patients after transfer of genetically engineered lymphocytes
    • Morgan RA, Dudley ME, Wunderlich JR, et al. Cancer regression in patients after transfer of genetically engineered lymphocytes. Science. 2006;314:126-9.
    • (2006) Science , vol.314 , pp. 126-129
    • Morgan, R.A.1    Dudley, M.E.2    Wunderlich, J.R.3
  • 20
    • 0035378334 scopus 로고    scopus 로고
    • A key role for ICAM-1 in generating effector cells mediating inflammatory responses
    • Camacho SA, Heath WR, Carbone FR, et al. A key role for ICAM-1 in generating effector cells mediating inflammatory responses. Nature Immunol. 2001;2:523-9.
    • (2001) Nature Immunol. , vol.2 , pp. 523-529
    • Camacho, S.A.1    Heath, W.R.2    Carbone, F.R.3
  • 21
    • 20044363610 scopus 로고    scopus 로고
    • CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells
    • Antony PA, Piccirillo CA, Akpinarli A, et al. CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells. J Immunol. 2005;174:2591-601.
    • (2005) J. Immunol. , vol.174 , pp. 2591-2601
    • Antony, P.A.1    Piccirillo, C.A.2    Akpinarli, A.3
  • 22
    • 19944430491 scopus 로고    scopus 로고
    • Tim-3+ T-bet+ tumor-specific Th1 cells colocalize with and inhibit development and growth of murine neoplasms
    • Simmons WJ, Koneru M, Mohindru M, et al. Tim-3+ T-bet+ tumor-specific Th1 cells colocalize with and inhibit development and growth of murine neoplasms. J Immunol. 2005;174:1405-15.
    • (2005) J. Immunol. , vol.174 , pp. 1405-1415
    • Simmons, W.J.1    Koneru, M.2    Mohindru, M.3
  • 23
    • 1642556833 scopus 로고    scopus 로고
    • T-bet regulates metastasis rate in a murine model of primary prostate cancer
    • Peng SL, Townsend MJ, Hecht JL, et al. T-bet regulates metastasis rate in a murine model of primary prostate cancer. Cancer Res. 2004;64:452-5.
    • (2004) Cancer Res. , vol.64 , pp. 452-455
    • Peng, S.L.1    Townsend, M.J.2    Hecht, J.L.3
  • 24
    • 29144514645 scopus 로고    scopus 로고
    • Effector memory T cells, early metastasis, and survival in colorectal cancer
    • Pages F, Berger A, Camus M, et al. Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med. 2005;353:2654-66.
    • (2005) N. Engl. J. Med. , vol.353 , pp. 2654-2666
    • Pages, F.1    Berger, A.2    Camus, M.3
  • 25
    • 30044434147 scopus 로고    scopus 로고
    • Priming of T cells by exogenous antigen cross-presented on MHC class I molecules
    • Shen L, Rock KL. Priming of T cells by exogenous antigen cross-presented on MHC class I molecules. Curr Opin Immunol. 2006;18:85-91.
    • (2006) Curr. Opin. Immunol. , vol.18 , pp. 85-91
    • Shen, L.1    Rock, K.L.2
  • 26
    • 0035905477 scopus 로고    scopus 로고
    • Cytokine-driven proliferation and differentiation of human naive, central memory, and effector memory CD4 (+) T cells
    • Geginat J, Sallusto F, Lanzavecchia A. Cytokine-driven proliferation and differentiation of human naive, central memory, and effector memory CD4 (+) T cells. J Exp Med. 2001;194:1711-9.
    • (2001) J. Exp. Med. , vol.194 , pp. 1711-1719
    • Geginat, J.1    Sallusto, F.2    Lanzavecchia, A.3
  • 27
    • 0141796316 scopus 로고    scopus 로고
    • Duration of antiviral immunity after smallpox vaccination
    • Hammarlund E, Lewis MW, Hansen SG, et al. Duration of antiviral immunity after smallpox vaccination. Nat Med. 2003;9:1131-7.
    • (2003) Nat. Med. , vol.9 , pp. 1131-1137
    • Hammarlund, E.1    Lewis, M.W.2    Hansen, S.G.3
  • 28
    • 0037174674 scopus 로고    scopus 로고
    • Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes
    • Dudley M, Wunderlich J, Robbins P, et al. Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science. 2002;298:850-4.
    • (2002) Science , vol.298 , pp. 850-854
    • Dudley, M.1    Wunderlich, J.2    Robbins, P.3
  • 29
    • 0034650421 scopus 로고    scopus 로고
    • Cutting edge: CD4+ T cell control of CD8+ T cell reactivity to a model tumor antigen
    • Surman DR, Dudley ME, Overwijk WW, Restifo NP. Cutting edge: CD4+ T cell control of CD8+ T cell reactivity to a model tumor antigen. J Immunol. 2000;164:562-5.
    • (2000) J. Immunol. , vol.164 , pp. 562-565
    • Surman, D.R.1    Dudley, M.E.2    Overwijk, W.W.3    Restifo, N.P.4
  • 30
    • 0032477815 scopus 로고    scopus 로고
    • Induction of antigen-specific T cell anergy: An early event in the course of tumor progression
    • Staveley-O'Carroll K, Sotomayor E, Montgomery J, et al. Induction of antigen-specific T cell anergy: an early event in the course of tumor progression. Proc Natl Acad Sci. 1998;95:1178-83.
    • (1998) Proc. Natl. Acad. Sci. , vol.95 , pp. 1178-1183
    • Staveley-O'Carroll, K.1    Sotomayor, E.2    Montgomery, J.3
  • 31
    • 0036569127 scopus 로고    scopus 로고
    • Cutting edge: Regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation
    • Woo EY, Yeh H, Chu CS, et al. Cutting edge: regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation. J Immunol. 2002;168:4272-6.
    • (2002) J. Immunol. , vol.168 , pp. 4272-4276
    • Woo, E.Y.1    Yeh, H.2    Chu, C.S.3
  • 32
    • 0036812718 scopus 로고    scopus 로고
    • Antigens derived from melanocyte differentiation proteins: Self-tolerance, autoimmunity, and use for cancer immunotherapy
    • Engelhard VH, Bullock TN, Colella TA, et al. Antigens derived from melanocyte differentiation proteins: self-tolerance, autoimmunity, and use for cancer immunotherapy. Immunol Rev. 2002;188:136-46.
    • (2002) Immunol. Rev. , vol.188 , pp. 136-146
    • Engelhard, V.H.1    Bullock, T.N.2    Colella, T.A.3
  • 33
    • 0033056073 scopus 로고    scopus 로고
    • Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients
    • Lee PP, Yee C, Savage PA, et al. Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients. Nat Med. 1999;5:677-85.
    • (1999) Nat. Med. , vol.5 , pp. 677-685
    • Lee, P.P.1    Yee, C.2    Savage, P.A.3
  • 35
    • 33748076467 scopus 로고    scopus 로고
    • Tumour-induced immune modulation of sentinel lymph nodes
    • Cochran AJ, Huang RR, Lee J, et al. Tumour-induced immune modulation of sentinel lymph nodes. Nat Rev Immunol. 2006;6:659-70.
    • (2006) Nat. Rev. Immunol. , vol.6 , pp. 659-670
    • Cochran, A.J.1    Huang, R.R.2    Lee, J.3
  • 38
    • 34249677872 scopus 로고    scopus 로고
    • Adoptive transfer of tumor-primed, in vitro-activated, CD4+ T effector cells (TEs) combined with CD8+ TEs provides intratumoral TE proliferation and synergistic antitumor response
    • Wang LX, Shu S, Disis ML, Plautz GE. Adoptive transfer of tumor-primed, in vitro-activated, CD4+ T effector cells (TEs) combined with CD8+ TEs provides intratumoral TE proliferation and synergistic antitumor response. Blood. 2007;109:4865-76.
    • (2007) Blood , vol.109 , pp. 4865-4876
    • Wang, L.X.1    Shu, S.2    Disis, M.L.3    Plautz, G.E.4
  • 39
    • 45549099784 scopus 로고    scopus 로고
    • Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1
    • Hunder NN, Wallen H, Cao J, et al. Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1. N Engl J Med. 2008;358:2698-703.
    • (2008) N. Engl. J. Med. , vol.358 , pp. 2698-2703
    • Hunder, N.N.1    Wallen, H.2    Cao, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.